Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1)A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8Activation of Src family kinases by colony stimulating factor-1, and their association with its receptorE2-RING expansion of the NEDD8 cascade confers specificity to cullin modificationAutocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architectureCyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivoN-terminal polyubiquitination and degradation of the Arf tumor suppressorPostnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinasesThe miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastomaAssembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenanceCasein kinase 1δ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesis.Structural Dissection of a Gating Mechanism Preventing Misactivation of Ubiquitin by NEDD8’s E1 † ‡The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup IdentitySubgroup-specific structural variation across 1,000 medulloblastoma genomesGlycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localizationCerebellum development and medulloblastomaDevelopment and cancer of the cerebellumProgressive hearing loss in mice lacking the cyclin-dependent kinase inhibitor Ink4dBax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesisApoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesisMyc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalizationStatistical significance threshold criteria for analysis of microarray gene expression data.Miz1 is required to maintain autophagic flux.INK4d-deficient mice are fertile despite testicular atrophyRescue of defective mitogenic signaling by D-type cyclins.Role of the miR-17∼92 cluster family in cerebellar and medulloblastoma development.The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.Embryonic Expression and Function of the Xenopus Ink4d Cyclin D-Dependent Kinase Inhibitor.Cyclin-dependent kinase inhibitors in the development of the central nervous system.Generation of Atoh1-rtTA transgenic mice: a tool for inducible gene expression in hair cells of the inner earArf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemiaIdentification of small molecule activators of BMP signalingMedulloblastoma: advances and challenges.WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation.Oncogenic potential of the c-FMS proto-oncogene (CSF-1 receptor).Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.Characterization of the oncogene (erb) of avian erythroblastosis virus and its cellular progenitorRoles of p53 and p27(Kip1) in the regulation of neurogenesis in the murine adult subventricular zoneDicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation.
P50
Q22009105-1997F295-9BF1-4FE0-83C7-B1A942AC0EEDQ24303664-5D20CB75-27BE-4EDD-B089-6273AE6F72ACQ24308705-EBA255E7-D076-484D-B274-D3592E3D7F04Q24316067-47603792-B646-49E9-BDC2-C178409B7296Q24338443-2C6EAF69-FBA1-4A5A-AA7D-9AB06DB2FA02Q24554696-E505D3F5-28FF-4C47-9D6F-0F8B2D83EA90Q24561681-3879B705-A249-4F95-A932-21753EC6347DQ24649057-A9094E4F-6109-4E6B-B7F7-61E922F56241Q24657463-1C457A22-E548-4E5E-8BC4-205A6397F997Q24685138-04F7BDED-24B3-45EF-9833-EEF2970AEB7EQ27310060-ACECD80F-76A8-4501-A1DE-F860539ECD2DQ27320896-4F74EF91-F77E-4B89-823B-AF0CD5F45CB9Q27651318-61953D2B-BB63-4B41-9D8D-7BDF8D4D3572Q28114769-C0511FB8-1AF4-496C-836D-9413DA390C30Q28271811-0FA6C0BD-08ED-4A0F-880D-52BEB8FCD8F5Q28290083-F62CA942-6C95-4AB9-989B-F4B9DA55892EQ28304753-0AE40D37-364B-42BC-89C2-B81A18879B8BQ28305235-AB6584C5-1A5D-4B8C-89A5-AB81EB6A166EQ28508628-0A77DEA1-B216-4023-A4C6-797D1DB2137AQ28513038-968CDAFB-D063-495C-B2BD-E0978BDE8BD9Q28593886-3D267A7F-1820-4AFB-817B-90F329D60504Q29614701-A6CBC91A-D4CC-4D41-B29C-B529570EF34BQ31038601-18B19005-6A77-41AD-86FA-9CCAFF23ECFBQ33854521-BCF3D53E-E523-4908-93BC-F364483F2000Q33961317-6D4F627F-65E0-42E0-8AC8-36972071F14EQ34080582-2E2782A6-C393-425E-8DB3-4DC20B07E47FQ34131951-139708CF-BCA7-4DD9-8BF4-A1F3FA81C80BQ34133633-EB3F4B38-7F7A-4FB1-B79F-5CBECC761BF8Q34318142-B048B8D3-E134-4B00-A65E-2BEA0B0CE170Q34336989-282DD107-AF49-4636-A6B9-9D3248BF4BAEQ34440429-A409C70E-979A-42EF-9137-5C4968440AC3Q34546468-95B301F0-84D3-4885-8A2D-B9D2C1B39896Q34634563-09D46B75-230F-4FD6-99D4-A13ED10608B6Q35002014-6E3F3825-A5CC-4C7D-BC1D-7EBCDBEB3CE2Q35058659-0E922D07-D189-4623-B87C-D46DB0207171Q35107129-81585BFB-7485-457A-84D8-1217911A6972Q35135650-3A1ECB95-801E-4094-8B7A-6F9A26DE522EQ35237524-5F31B527-E532-4113-9B2E-9451462ED69DQ35545392-D480DBCE-C320-46FD-9B64-2EB4127EBDBDQ35668665-E5A27835-F05A-43EB-B1F5-AABA2FDA7E65
P50
description
französisch-amerikanische Zellbiologien
@de
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Martine F Roussel
@ast
Martine F Roussel
@en
Martine F Roussel
@es
Martine F Roussel
@nl
Martine F Roussel
@sl
Martine F. Roussel
@de
type
label
Martine F Roussel
@ast
Martine F Roussel
@en
Martine F Roussel
@es
Martine F Roussel
@nl
Martine F Roussel
@sl
Martine F. Roussel
@de
altLabel
Martine F. Roussel
@en
Martine Roussel
@de
Martine Roussel
@en
prefLabel
Martine F Roussel
@ast
Martine F Roussel
@en
Martine F Roussel
@es
Martine F Roussel
@nl
Martine F Roussel
@sl
Martine F. Roussel
@de
P214
P1053
F-1469-2016
P106
P21
P214
P31
P3829
P496
0000-0002-1740-8139
P569
1950-01-01T00:00:00Z
P734
P735
P7859
viaf-202194858